Welcome to Jianke online pharmacy! Sign in Free registration
reminder:The pictures are the real photos of the original products taken by Jianke for reference only; In case of new packaging listing, there may be update lag, please take the physical object as the standard!
Baidu certification

Lamivudine tablets (heptin)

It is suitable for the treatment of adult chronic hepatitis B patients with alanine aminotransferase [ALT] elevation, viral activity replication and liver function compensation. More role
App download minus 10 yuan
Common name:
Lamivudine tablets
Product No.:
B14202000442
Approval No.:
Gyzz h20030581 (inquired by the State Drug Administration)
Jianke price:
¥199.00
Product specification:
0.1g*14s
Manufacturer:
GlaxoSmithKline Pharmaceutical (Suzhou) Co., Ltd
number        Quantity:
Add to list
Tips:
This product is a prescription drug. Please buy it with the prescription paper; Delivered by Jianke offline drugstore
 
(for assistance, please call400-086-5111
Jianke promises:
Genuine guarantee
Bank remittance / transfer online payment
  • Product introduction
  • instructions
  • Qualification certificate
  • Relevant information
Product name Lamivudine tablets (heptin)
Main raw materials The main ingredient of this product is lamivudine.
Main role It is suitable for the treatment of adult chronic hepatitis B patients with alanine aminotransferase [ALT] elevation, viral activity replication and liver function compensation.
Product specification 0.1g*14s
Usage and dosage Oral, 0.1g for adults once a day. See the inner packaging instructions for details.
manufacturing enterprise GlaxoSmithKline Pharmaceutical (Suzhou) Co., Ltd
Jianke commitment
  • Genuine guarantee, formal invoice

    Jianke.com is an approved (B2C) Internet drug legitimate business enterprise in Guangdong Province. It signs a direct supply agreement with the manufacturer and can issue formal invoices for the purchased goods.

  • Private packaging, privacy protection

    When jianke.com packages and delivers goods, the appearance of the packing box only displays the necessary information for delivery, and the name of the purchased goods will not appear. The specific shopping list is in the package to protect the privacy of customers.

  • Efficient logistics and safe arrival

    All products of jianke.com adopt the door-to-door distribution mode of third-party logistics. They are delivered to the nearest warehouse according to your distribution address, so as to deliver them to you on time.

  • Three warehouses to ensure inventory

    Jianke.com has three warehouses in Guangzhou, Dongguan and Wuhan, equipped with first-class equipment, constant temperature and humidity to ensure drug quality. Specially assigned person to manage and ensure product inventory.

[drug name] Lamivudine tablets (heptin)

[common name] Lamivudine tablets

[specification and model] 0.1g*14s

[manufacturer] GlaxoSmithKline Pharmaceutical (Suzhou) Co., Ltd

[drug type] Western medicine

[approval No.] Gyzz h20030581

[validity period] 36 months

[functional indications] It is suitable for the treatment of adult chronic hepatitis B patients with alanine aminotransferase [ALT] elevation, viral activity replication and liver function compensation.

[usage and dosage] Oral, 0.1g for adults once a day. See the inner packaging instructions for details.

[adverse reactions] Common adverse reactions include upper respiratory tract infection like symptoms, headache, nausea, physical discomfort, abdominal pain and diarrhea. The symptoms are generally mild and can be relieved by themselves. See the inner packaging instructions for details.

[precautions] 1. Patients should be reminded that lamivudine is not a drug that can cure hepatitis B. Patients must be given medication under the guidance of specialists who have experience in hepatitis B treatment, and can not stop their medication voluntarily, and they need regular monitoring during treatment. ALT levels should be measured at least every 3 months and HBV DNA and HBeAg should be measured every 6 months. 2. Patients with HBsAg positive but normal ALT level should not start lamivudine treatment even if HBeAg and / or HBV DNA are positive. They should be followed up regularly and considered according to the changes of their condition. 3. With the extension of lamivudine treatment time, the YMDD variant of hepatitis B virus can be detected in some patients, and the sensitivity of this variant to lamivudine decreases. Please read the instructions carefully and follow the doctor's advice.

[taboo] It is forbidden for those who are allergic to this product.

[listing Permit Holder] GlaxoSmithKline Pharmaceutical (Suzhou) Co., Ltd

[packaging unit] box

[main ingredients] The main ingredient of this product is lamivudine.

[character] This product is film coated tablets. It turns white after removing the film coating.

[applicable population] adult

[medication for pregnant and lactating women] Patients within 3 months of pregnancy should not use this product. Patients with more than 3 months of pregnancy need to weigh the advantages and disadvantages of using this product. Breastfeeding women should stop breastfeeding when taking this product.

[medication for children] There are no data on children's use of lamivudine in China.

[medication for elderly patients] See adult usage and dosage.

[storage] Shading, sealed storage.

Praise degree

zero%

    reminder

    Dear customer:

    In case of emergency, please call the ordering hotline400-086-5111Consult a health care professional pharmacist.

    Lamivudine tablets (heptin)

    ¥199.00

    reminder

    To ensure your privacy, please enter the verification code and click "confirm callback". Our customer service staff will call back the phone number you entered later!

    Please enter the correct verification code!
    Loding...
    Can't see clearly. Change one

    Dear customer:

    Your callback failed this time. Please re-enter the verification code to try. Thank you!